Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Leukemia

  Free Subscription


Articles published in Acta Haematol

Retrieve available abstracts of 41 articles:
HTML format
Text format



Single Articles


    June 2018
  1. PARK HS, Kim DY, Choi EJ, Lee JH, et al
    Blast Percentage of Bone Marrow Aspirate on Day 14 of Induction Chemotherapy Predicts Adult Acute Lymphoblastic Leukemia Treatment Outcomes.
    Acta Haematol. 2018;139:220-227.
    PubMed     Text format     Abstract available


    March 2018
  2. SCHNEIDEWEND R, Hosking P, Brazauskas R, Peterson J, et al
    Early Fluorescence in situ Hybridization Assessment during Acute Myeloid Leukemia Induction Chemotherapy.
    Acta Haematol. 2018;139:171-175.
    PubMed     Text format    


    February 2018
  3. SONG X, Peng Y, Wang X, Chen Y, et al
    Incidence, Survival, and Risk Factors for Adults with Acute Myeloid Leukemia Not Otherwise Specified and Acute Myeloid Leukemia with Recurrent Genetic Abnormalities: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database, 2001-201
    Acta Haematol. 2018;139:115-127.
    PubMed     Text format     Abstract available


  4. BRUNNER AM
    No Mutation Left Behind: The Impact of Reporting Recurrent Genetic Abnormalities on Outcomes of Patients with Acute Myeloid Leukemia.
    Acta Haematol. 2018;139:128-130.
    PubMed     Text format    


  5. BARON BW, Thirman MJ, Giurcanu MC, Baron JM, et al
    Quercetin Therapy for Selected Patients with PIM1 Kinase-Positive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pilot Study.
    Acta Haematol. 2018;139:132-139.
    PubMed     Text format     Abstract available


  6. TANG X, Zhou J, Zhang J, Zhou LY, et al
    Low Expression of FUS1 Is Negatively Correlated with miR-378 and May Predict Adverse Prognoses in Acute Myeloid Leukemia.
    Acta Haematol. 2018;139:89-95.
    PubMed     Text format     Abstract available


    January 2018
  7. NISCOLA P, Neri B, Morino L, de Fabritiis P, et al
    Monoclonal Gammopathy Responsive to Decitabine Given for Acute Myeloid Leukemia in a Frail Patient.
    Acta Haematol. 2018;139:58-59.
    PubMed     Text format    


    September 2017
  8. LEADER A, Raanani P
    Switching-On Adherence in Chronic Myeloid Leukemia.
    Acta Haematol. 2017;138:138-139.
    PubMed     Text format    


  9. MAEDA Y, Okamoto A, Kawaguchi SI, Konishi A, et al
    Improved Drug Adherence in Patients with Chronic Myeloid Leukemia in the Chronic Phase by Switching to Second-Generation Tyrosine Kinase Inhibitors.
    Acta Haematol. 2017;138:140-142.
    PubMed     Text format    


  10. LIEBERMAN F, Villgran V, Normolle D, Boyiadzis M, et al
    Intracranial Hemorrhage in Patients Newly Diagnosed with Acute Myeloid Leukemia and Hyperleukocytosis.
    Acta Haematol. 2017;138:116-118.
    PubMed     Text format    


    July 2017
  11. TIMMERMANS K, Leijte GP, Kox M, Scheffer GJ, et al
    Release of Danger-Associated Molecular Patterns following Chemotherapy Does Not Induce Immunoparalysis in Leukemia Patients.
    Acta Haematol. 2017;138:39-43.
    PubMed     Text format     Abstract available


  12. ANAGNOSTOPOULOU E, Papanastasopoulou C, Papastamataki M, Kotsiou A, et al
    Serum Hyaluronic Acid Levels Are Altered in Acute Leukemia Patients: Potential Prognostic Implications.
    Acta Haematol. 2017;138:44-51.
    PubMed     Text format     Abstract available


  13. HERNANDEZ-RIVAS JA, Gonzalez-Gascon Y Marin I
    Genetic Heterogeneity in Chronic Lymphocytic Leukemia: What Can Conventional Cytogenetics Add?
    Acta Haematol. 2017;138:31-32.
    PubMed     Text format    


    June 2017
  14. CHANG H, Kuo MC, Tang TC, Lin TL, et al
    Clinical Features and Recurrence Pattern of Perianal Abscess in Patients with Acute Myeloid Leukemia.
    Acta Haematol. 2017;138:10-13.
    PubMed     Text format     Abstract available


    May 2017
  15. PETERSON JF, Shah R, Kobrinski D
    Two Distinct BCL2 Rearrangements, Each Observed in 2 Independent Subclones, Evolving from a Founder Clone with Trisomy 12 in a Unique Case of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
    Acta Haematol. 2017;137:237-239.
    PubMed     Text format    


    April 2017
  16. ZHAO H, Xu L, Yang Y, Shao J, et al
    Successful Management of Decitabine prior to Full-Dose Idarubicin and Cytarabine in the Treatment of Refractory/Recurrent Acute Myeloid Leukemia.
    Acta Haematol. 2017;137:195-200.
    PubMed     Text format     Abstract available


  17. LI Y, Wang CL, Din B, Yu L, et al
    Continuing Imatinib Treatment for Chronic Myeloid Leukemia Patients Who Had Serious Adverse Events at the Onset of Therapy.
    Acta Haematol. 2017;137:158-162.
    PubMed     Text format    


  18. PTACKOVA P, Petrackova M, Hindos M, Duskova M, et al
    Intracellular Cytokines Produced by Stimulated CD3+ Cells from Chronic Myeloid Leukemia Patients.
    Acta Haematol. 2017;137:148-157.
    PubMed     Text format     Abstract available


    January 2017
  19. QUINTELA A, Sujobert P, Callet-Bauchu E, Salles G, et al
    Ibrutinib-Induced Lymphocytosis: Cytological Features.
    Acta Haematol. 2017;137:55-57.
    PubMed     Text format    


  20. LONGU F, Fozza C, Dessi L, Longinotti M, et al
    Fludarabine and Cytarabine Combination in the Induction of Adult Patients with Acute Myeloid Leukaemia.
    Acta Haematol. 2017;137:15-16.
    PubMed     Text format    


  21. GUREVICH-SHAPIRO A, Tzadok S, Rosenberg A, Inbal A, et al
    Extended Small-Dose Platelet Transfusions in Multitransfused Hemato-Oncological Patients: A Single-Center Experience.
    Acta Haematol. 2017;137:183-190.
    PubMed     Text format     Abstract available


  22. LIANG Y, Gao J, Wu D, Li S, et al
    Long-Term Remission following Autologous Hematopoietic Cell Transplantation in a Patient with Multiple Nonleukemic Myeloid Sarcoma and a Review of the Literature.
    Acta Haematol. 2017;137:117-122.
    PubMed     Text format     Abstract available


  23. SCHNEIDEWIND L, Neumann T, Knoll F, Zimmermann K, et al
    Are the Polyomaviruses BK and JC Associated with Opportunistic Infections, Graft-versus-Host Disease, or Worse Outcomes in Adult Patients Receiving Their First Allogeneic Stem Cell Transplantation with Low-Dose Alemtuzumab?
    Acta Haematol. 2017;138:3-9.
    PubMed     Text format     Abstract available


    November 2016
  24. SHENG G, Zeng Z, Pan J, Wang Q, et al
    t(1;9)(p34;q34)/SFPQ-ABL1 Fusion in a Patient with Ph-Like Common B-Cell Acute Lymphoblastic Leukemia.
    Acta Haematol. 2016;137:40-43.
    PubMed     Text format    


    October 2016
  25. MORI N, Ohwashi-Miyazaki M, Okada M, Yoshinaga K, et al
    Translocation (9;12)(q34.1;p13.3) Resulted in ETV6-ABL1 Fusion in a Patient with Philadelphia Chromosome-Negative Chronic Myelogenous Leukemia.
    Acta Haematol. 2016;136:240-243.
    PubMed     Text format    


    September 2016
  26. BALJEVIC M, Dumitriu B, Lee JW, Paietta EM, et al
    Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic Leukemia.
    Acta Haematol. 2016;136:210-218.
    PubMed     Text format     Abstract available


    August 2016
  27. HULEGARDH E, Punab M, Holmberg E, Palk K, et al
    Acute de novo Leukemia in Estonia and Western Sweden 1982-2006: Positive Trend in the Survival of Acute Leukemia over 25 Years.
    Acta Haematol. 2016;136:167-173.
    PubMed     Text format     Abstract available


  28. KAMODA Y, Izumi K, Iioka F, Akasaka T, et al
    Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Is Separated into Two Subgroups Associated with Survival by BCR-ABL Fluorescence in situ Hybridization of Segmented Cell Nuclei: Report from a Single Institution.
    Acta Haematol. 2016;136:157-166.
    PubMed     Text format     Abstract available


    May 2016
  29. BYUN JM, Lee JO, Bang SM, Yu ES, et al
    8p11 Myeloproliferative Syndrome with t(7;8) Translocation Presenting as Acute Myeloid Leukemia: A Case Report and Literature Review.
    Acta Haematol. 2016;136:71-75.
    PubMed     Text format    


    April 2016
  30. YAN W, Zhang G
    Molecular Characteristics and Clinical Significance of 12 Fusion Genes in Acute Promyelocytic Leukemia: A Systematic Review.
    Acta Haematol. 2016;136:1-15.
    PubMed     Text format     Abstract available


    March 2016
  31. LI X, Zhu H, Zhang Y, Zhao W, et al
    The Time to Clearance of Peripheral Blood Blasts Predicts Complete Remission and Survival in Chinese Adults with Acute Myeloid Leukemia.
    Acta Haematol. 2016;135:217-223.
    PubMed     Text format     Abstract available


    January 2016
  32. SCHILLER GJ
    High-Intensity Induction in the Elderly.
    Acta Haematol. 2016;135:53-4.
    PubMed     Text format    


  33. FARINA M, Rossi G, Bellotti D, Marchina E, et al
    Is Having Clonal Cytogenetic Abnormalities the Same as Having Leukaemia.
    Acta Haematol. 2016;135:39-42.
    PubMed     Text format     Abstract available


  34. KAEDA J, Ringel F, Oberender C, Gresse M, et al
    Longitudinal Study to Assess the Clinical Significance of MSI2 Expression in Chronic Myeloid Leukemia Patients.
    Acta Haematol. 2016;136:62-4.
    PubMed     Text format    


  35. SANTOLERI F, Lasala R, Ranucci E, La Barba G, et al
    Medication Adherence to Tyrosine Kinase Inhibitors: 2-Year Analysis of Medication Adherence to Imatinib Treatment for Chronic Myeloid Leukemia and Correlation with the Depth of Molecular Response.
    Acta Haematol. 2016;136:45-51.
    PubMed     Text format     Abstract available


  36. AMITAI I, Leader A, Raanani P
    Adherence to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: The Challenge That Lies Ahead.
    Acta Haematol. 2016;136:43-4.
    PubMed     Text format    


  37. NORSWORTHY KJ, Bhatnagar B, Singh ZN, Gojo I, et al
    Myeloid Sarcoma of the Hepatobiliary System: A Case Series and Review of the Literature.
    Acta Haematol. 2016;135:241-51.
    PubMed     Text format     Abstract available


  38. ALSHIEKH-NASANY R, Douer D
    L-Carnitine for Treatment of Pegasparaginase-Induced Hepatotoxicity.
    Acta Haematol. 2016;135:208-10.
    PubMed     Text format     Abstract available


  39. SHANSHAL M, Shakespeare A, Thirumala S, Fenton B, et al
    Dasatinib-Induced T-Cell-Mediated Colitis: A Case Report and Review of the Literature.
    Acta Haematol. 2016;136:219-228.
    PubMed     Text format     Abstract available


  40. GONG D, Li W, Hu LD, Shen JL, et al
    Comparison of Clinical Efficacy of Cytarabine with Different Regimens in Postremission Consolidation Therapy for Adult t(8;21) AML Patients: A Multicenter Retrospective Study in China.
    Acta Haematol. 2016;136:201-209.
    PubMed     Text format     Abstract available


  41. ZHANG G, Dong F, Luan C, Zhang X, et al
    Overexpression of CCAAT Enhancer-Binding Protein alpha Inhibits the Growth of K562 Cells via the Foxo3a-Bim Pathway.
    Acta Haematol. 2016;136:65-70.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: